You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 120 No. 6, June 1985 TABLE OF CONTENTS
  Archives
  •  Online Features
  PAPERS READ BEFORE THE 92ND ANNUAL MEETING OF THE WESTERN SURGICAL ASSOCIATION, COLORADO SPRINGS, COLO, NOV 12-14, 1984-PART II
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (118)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Perioperative Allogeneic Blood Transfusions

Survival in Patients With Resected Carcinomas of the Colon and Rectum

S. David Nathanson, MB, BCh, FRCS(Edin); Barbara C. Tilley, PhD; Lonni Schultz, MS; Roger F. Smith, MD

Arch Surg. 1985;120(6):734-738.


Abstract

• Blood transfusion (BT) is reported to cause immunosuppression. We postulated that BT might therefore adversely affect the prognosis of carcinomas of the colon and rectum. We analyzed the overall and recurrence-free survival of 366 patients whose colorectal carcinomas were resected. The 199 patients who received perioperative BTs appeared to survive less well than the 167 patients who received no blood products. However, Cox analysis, which adjusts for other prognostic variables, shows that the difference was not statistically significant. Although 43% of transfused patients survived, as compared with 56.5% of nontransfused patients, this difference was due to variables other than transfusion. This study did not support the hypothesis that BT has an adverse effect on survival of patients with colorectal cancer.

(Arch Surg 1985;120:734-738)



Author Affiliations

From the Departments of Surgery (Drs Nathanson and Smith) and Biostatistics (Dr Tilley and Ms Schultz), Henry Ford Hospital, Detroit.


Footnotes

Accepted for publication Feb 12, 1985.

Read before the 92nd annual meeting of the Western Surgical Association, Colorado Springs, Colo, Nov 14, 1984.

Reprint requests to Department of Surgery, Henry Ford Hospital, 2799 W Grand Blvd, Detroit, MI 48202 (Dr Nathanson).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Long-term Survival in the Intensive Care Unit After Erythrocyte Blood Transfusion
Engoren and Arslanian-Engoren
Am J Crit Care 2009;18:124-131.
ABSTRACT | FULL TEXT  

Effect of blood transfusion on long-term survival after cardiac operation
Engoren et al.
Ann. Thorac. Surg. 2002;74:1180-1186.
ABSTRACT | FULL TEXT  

Leukocyte-Reduced Blood Transfusions: Perioperative Indications, Adverse Effects, and Cost Analysis
Sharma et al.
Anesth. Analg. 2000;90:1315-1323.
FULL TEXT  

Blood Transfusions and Prognosis in Colorectal Cancer
Busch et al.
NEJM 1993;328:1372-1376.
ABSTRACT | FULL TEXT  

Blood Transfusion and Other Risk Factors for Recurrence of Cancer of the Head and Neck
Jones and Weissler
Arch Otolaryngol Head Neck Surg 1990;116:304-309.
ABSTRACT  

Effect of Blood Transfusion on Antigen Presentation Function and on Interleukin 2 Generation
Stephan et al.
Arch Surg 1988;123:235-240.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1985 American Medical Association. All Rights Reserved.